HC Wainwright & Co. Reiterates Buy on Plus Therapeutics, Announces $8 Price Target

Benzinga · 11/26 11:27
HC Wainwright & Co. analyst Sean Lee reiterates Plus Therapeutics (NASDAQ:PSTV) with a Buy and announces $8 price target.